MetLife Investment Management’s Antares Pharma, Inc. ATRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-84,197
| Closed | -$345K | – | 2945 |
|
|
2022
Q1 | $345K | Buy |
84,197
+47,767
| +131% | +$196K | ﹤0.01% | 2010 |
|
|
2021
Q4 | $130K | Sell |
36,430
-23,939
| -40% | -$85.5K | ﹤0.01% | 2307 |
|
|
2021
Q3 | $220K | Buy |
60,369
+20,612
| +52% | +$75K | ﹤0.01% | 2028 |
|
|
2021
Q2 | $173K | Sell |
39,757
-27,056
| -40% | -$118K | ﹤0.01% | 2242 |
|
|
2021
Q1 | $275K | Buy |
66,813
+19,845
| +42% | +$81.6K | ﹤0.01% | 1871 |
|
|
2020
Q4 | $187K | Buy |
46,968
+9,208
| +24% | +$36.7K | ﹤0.01% | 2018 |
|
|
2020
Q3 | $102K | Sell |
37,760
-31,821
| -46% | -$85.9K | ﹤0.01% | 2204 |
|
|
2020
Q2 | $191K | Hold |
69,581
| – | – | ﹤0.01% | 1935 |
|
|
2020
Q1 | $164K | Hold |
69,581
| – | – | ﹤0.01% | 1798 |
|
|
2019
Q4 | $327K | Hold |
69,581
| – | – | ﹤0.01% | 1693 |
|
|
2019
Q3 | $233K | Hold |
69,581
| – | – | ﹤0.01% | 1864 |
|
|
2019
Q2 | $229K | Hold |
69,581
| – | – | ﹤0.01% | 1951 |
|
|
2019
Q1 | $211K | Hold |
69,581
| – | – | ﹤0.01% | 1954 |
|
|
2018
Q4 | $189K | Hold |
69,581
| – | – | ﹤0.01% | 1937 |
|
|
2018
Q3 | $234K | Sell |
69,581
-2,150
| -3% | -$7.22K | ﹤0.01% | 2004 |
|
|
2018
Q2 | $185K | Hold |
71,731
| – | – | ﹤0.01% | 1954 |
|
|
2018
Q1 | $158K | Buy |
71,731
+52,911
| +281% | +$117K | ﹤0.01% | 2015 |
|
|
2017
Q4 | $37K | Buy |
+18,820
| New | +$37K | ﹤0.01% | 2215 |
|